IFNγ enhances ferroptosis under erastin or RSL3 treatment by promoting STAT1 binding to the SLC7A11 promoter, depleting GSH, and increasing lipid peroxidation in tumor cells [10,31]. The gene discussed is IFNG; the disease is neoplasm.